Clinical Trials Logo

Filter by:
NCT ID: NCT03880123 Withdrawn - Sarcoma Clinical Trials

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Start date: November 2020
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to establish a safe and tolerable dose combination (the "maximum tolerated dose") of selinexor and ixazomib when used together for the treatment of patients with certain types of advanced sarcoma. The study will enroll patients with advanced dedifferentiated liposarcoma, malignant peripheral nerve sheath tumor, alveolar soft part sarcoma and Ewing sarcoma. Future studies to further evaluate the safety and anti-cancer efficacy of this treatment for sarcoma will use the dose combination determined in this study.

NCT ID: NCT03879707 Withdrawn - Pain After TJA Clinical Trials

Improving Sleep Quality After Total Joint Arthroplasty ( TJA)

Start date: June 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is the evaluate and improve sleep quality after Total joint replacement.

NCT ID: NCT03877549 Withdrawn - Post Operative Pain Clinical Trials

Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery

Start date: May 24, 2019
Phase: Phase 4
Study type: Interventional

This study will evaluate the ability of dexamethasone to enhance labor epidurals when administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing elective cesarean sections will be randomized into three groups, each receiving the same combined spinal epidural (CSE). At surgical closure, Group 1 will receive 10cc bupivacaine 0.0625%, Group 2 will receive 10cc bupivacaine 0.0625% +4mg dexamethasone, and Group 3 will receive 10cc bupivacaine 0.0625% + 8mg dexamethasone (4mg). VAS, sedation, nausea, and satisfaction scoring will be measured on patient follow-up to compare the outcomes of the different treatment groups.

NCT ID: NCT03877250 Withdrawn - Clinical trials for Non Small Cell Lung Cancer

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Start date: March 8, 2019
Phase:
Study type: Observational

The purpose of this study is to attempt to obtain an on-treatment biopsy in participants with non-small cell lung cancer who are receiving standard treatment with a drug that targets the PD-1 or PD-L1 protein.

NCT ID: NCT03876548 Withdrawn - Clinical trials for Keloid Scar Following Surgery

Initial Assessment of a Topical Cadexomer Iodine Gel Efficacy on Keloid Scar Revision

Start date: February 7, 2019
Phase: Early Phase 1
Study type: Interventional

This is a 6 month, single site, interventional, open label prospective clinical study to evaluate the effects of a cadexomer iodine gel on the prevention of recurrent keloid formation in patients undergoing keloid scar revision.

NCT ID: NCT03876158 Withdrawn - Chronic Pain Clinical Trials

Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)

TRANSIT
Start date: October 2019
Phase: Phase 4
Study type: Interventional

Flowonix Prometra® II Programmable Pump may require a smaller dose of drug when converting from other commercially available intrathecal drug delivery systems (IDDS).

NCT ID: NCT03875053 Withdrawn - Clinical trials for Locally Advanced Head and Neck Squamous Cell Carcinoma

Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer

Start date: July 25, 2023
Phase: N/A
Study type: Interventional

This trial studies information from a home sleep apnea machine to evaluate obstructive sleep apnea in patients with stage III-IV head and neck cancer. Sleep apnea (trouble breathing during sleep) can occur in head and neck cancer patients who have swelling in their neck. Wearing a sleep apnea machine overnight may help doctors evaluate obstructive sleep apnea in patients with head and neck cancer.

NCT ID: NCT03874845 Withdrawn - Clinical trials for Post Traumatic Stress Disorder

Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD)_VA Only

Start date: January 29, 2022
Phase: N/A
Study type: Interventional

This study will examine the effects of psychotherapy as treatment for PTSD. This research will see how brain activity and brain connectivity is affected by Mindfulness Based Cognitive Therapy (MBCT) and Muscle Relaxation Therapy (MRT). Participants that qualify to be in this study will receive 8 weeks of group therapy in MBCT or MRT. Prior to receiving therapy participants will: complete baseline assessments related to their PTSD; fill out surveys; have an functional magnetic resonance imaging (fMRI); and provide a saliva sample. These assessments will be repeated after the therapy is over. Overall study participation should last approximately 10-12 weeks.

NCT ID: NCT03874806 Withdrawn - Pain, Postoperative Clinical Trials

Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block

Start date: July 1, 2019
Phase: Phase 4
Study type: Interventional

The goals of this study are as follows: 1. to confirm the safe dosing of ropivacaine for the erector spinae plane block 2. develop a pharmacokinetic profile of the erector spinae plane block, which will help demonstrate how quickly and how closely toxic levels are reached when a routine dose of ropivacaine is given for this nerve block 3. assess numbness created by the erector spinae block when routine doses are administered

NCT ID: NCT03874767 Withdrawn - Hip Fractures Clinical Trials

Can Mobility Technicians Provide Value to Hospitalized Patients?

Start date: December 2022
Phase: N/A
Study type: Interventional

The specific aim of this study is to determine the impact of the addition of a dedicated mobility technician to the care team on specialty specific outcomes for patients recovering from surgical treatment for a hip or lower extremity long bone fracture or a lung transplant. The practice of post-operative early ambulation has been shown to improve outcomes by promoting enhanced recovery after surgery in a variety of patients. To that end, VUMC is establishing a "Culture of Mobility". To do so, additional personnel are being hired to help ambulate patients with traumatic hip and femur fractures, other fractures of the lower extremity long bones, as well as those post-lung transplant or readmitted post-lung transplant based upon the best available evidence supporting mobility programs. The added personnel are needed as the currently available resources have insufficient bandwidth to ensure complete early ambulation for all patients. The relative effectiveness of adding a dedicated resource is assumed. Although the literature suggests adding person-hours increases the amount of mobility achieved, there is an opportunity to evaluate whether this is really the case. The goal of this study is to evaluate the impact of adding the mobility technician to the existing care team. The mobility technician will be assisting patients who could benefit from early ambulation after surgery. We hypothesize that by adding this staffing resource, more patients will get the appropriate level of usual care. Specifically, we expect that adding the resource increases the proportion of those patients who are receiving the prescribed amount of early ambulation post-surgery, with subsequent improvements in functional independence at discharge, and decreases length of stay since patients achieve readiness for discharge sooner.